US Patent Issued to Cephalon on Sept. 9 for "Polynucleotides encoding antibodies that specifically bind to human IL-15" (Australian Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,247, issued on Sept. 9, was assigned to Cephalon LLC (West Chester, Pa.).

"Polynucleotides encoding antibodies that specifically bind to human IL-15" was invented by David Jose Simon Laine (Macquarie Park, Australia), Matthew Pollard (Pullenvale, Australia), Anthony Gerard Doyle (Macquarie Park, Australia), Lynn Dorothy Poulton (Macquarie Park, Australia) and Adam William Clarke (Macquarie Park, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Recombinant antibodies that specifically bind to IL-15 as well as a complex of IL-15 and the IL-15 Receptor-alpha are provided. The antibodies inhibit immune cell proliferation, and are capable of use...